MacroGenics to Participate in Upcoming Investor Conferences

25.04.2023 - ROCKVILLE, MD, April 24, 2023 (GLOBE NEWSWIRE) - MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercializing innovative antibody-based therapeutics for the treatment of cancer, today announced that the ...

Related Keywords

Rockville , New York , United States , Scott Koenig , Hc Wainwright Bioconnect , Jim Karrels , Securities Life Sciences Conference New York , Macrogenics The Company , Macrogenics Inc , Nasdaq , Oncology Days , Macrogenic President , Bioconnect Investor Conference , Life Sciences Conference , Investor Relations , Senior Vice President ,